Insulin pump use during hospitalization may improve glycemic outcomes and reduce length of stay for people with diabetes, ...

Indicated for people with Type 2 diabetes, the system would be Insulet’s first fully automated device for insulin delivery.

In 2024, Insulet shared results from its landmark SECURE-T2D pivotal trial, demonstrating improved glycemic outcomes with Omnipod 5 compared with prior insulin injection or pump therapy in adults with ...

It can acutely raise blood glucose levels by suppressing insulin secretion, but in the long term, it may confer metabolic ...

The FDA has approved the Control-IQ+ automated insulin delivery system for use in pregnant women with type 1 diabetes, ...

The document establishes, for the first time, a structured and standardised national framework for the screening, diagnosis, ...

Have you ever gotten sticker shock at the pharmacy counter? Your doctor writes you a new prescription, you go to the pharmacy ...

A major catalyst window opens for this biopharma stock with Q1 earnings due on May 6, and two key FDA decisions in May and ...

Small internal tears in Omnipod 5 insulin pump pods could lead to underdosing ...

Tandem Diabetes Care has announced that the U.S. Food and Drug Administration (FDA) has cleared Control-IQ+ automated insulin delivery (AID) technology for use in pregnancy complicated by ...

From side effects to misuse, what patients should know before using GLP-1 weight-loss drugs ...

In this Managed Healthcare Executive Between the Lines video series, Estay Greene, Pharm.D., MBA, and Victoria Bouhairie, M.D ...